Results 11 to 20 of about 9,499,844 (341)
Degenerative musculoskeletal diseases are structural and functional failures of the musculoskeletal system, including osteoarthritis, osteoporosis, intervertebral disc degeneration (IVDD), and sarcopenia.
Ze-Qin Wen +5 more
doaj +2 more sources
To provide evidence‐based recommendations on the use of vaccinations in children and adults with rheumatic and musculoskeletal diseases (RMDs).
A. Bass +40 more
semanticscholar +2 more sources
As the number of reports of post-acute COVID-19 musculoskeletal manifestations is rapidly rising, it is important to summarize the current available literature in order to shed light on this new and not fully understood phenomenon.
J. Ciaffi +11 more
semanticscholar +1 more source
Objectives Fatigue is prevalent in people with inflammatory rheumatic and musculoskeletal diseases (I-RMDs) and recognised as one of the most challenging symptoms to manage.
E. Dures +25 more
semanticscholar +1 more source
Cell‐Based Therapies for Degenerative Musculoskeletal Diseases
Degenerative musculoskeletal diseases (DMDs), including osteoporosis, osteoarthritis, degenerative disc disease, and sarcopenia, present major challenges in the aging population.
Pengbin Yin +8 more
semanticscholar +1 more source
Salvia miltiorrhiz, commonly known as “Danshen” in Chinese medicine, has longstanding history of application in cardiovascular and cerebrovascular diseases.
Zhiqiang Ye +9 more
semanticscholar +1 more source
Novel insights into the METTL3-METTL14 complex in musculoskeletal diseases
N6-methyladenosine (m^6A) modification, catalyzed by methyltransferase complexes (MTCs), plays many roles in multifaceted biological activities. As the most important subunit of MTCs, the METTL3-METTL14 complex is reported to be the initial factor that ...
Yeqiu Xu +6 more
semanticscholar +1 more source
Ferroptosis is a novel type of cell death associated with iron accumulation and excessive lipid peroxidation. Elucidating the underlying molecular mechanisms of ferroptosis is intensively related to the development and treatment of multiple diseases ...
Fan Zhang +7 more
semanticscholar +1 more source
Objective To develop recommendations for cardiovascular risk (CVR) management in gout, vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD), Sjögren’s syndrome (SS), systemic lupus erythematosus (SLE) and ...
G. Drosos +27 more
semanticscholar +1 more source
Background Musculoskeletal diseases affect 1.71 billion people worldwide, impose a high biopsychosocial burden on patients, and are associated with high economic costs.
Johanna Nagel +3 more
semanticscholar +1 more source

